Cutting-edge innovation driven by our purpose
Since 2014, Freenome has had a clear vision—to detect cancer in its earliest, most treatable stages.
We are values-led
At Freenome, our values guide everything we do.
STRIVE FOR GREATNESS
We choose to take on cancer not because it’s easy, but because it’s hard.
SERVANT LEADERSHIP
We lead by example and help others grow to their full potential.
TRUST
We recognize trust is built over time and value long-term relationships, not short-term transactions.
INTEGRITY
We courageously do what is right, and are fact-based, data-driven, and accountable for results.
EMPATHY
We seek to understand before being understood and build products that equitably serve diverse communities.
Leadership
Riley Ennis
Co-Founder and
Chief Product Officer
Jimmy Lin, M.D., Ph.D., MHS
Chief Scientific Officer
Julie Tran, MSHR
Chief People Officer
Sally Howard, J.D.
Senior Vice President,
Regulatory and Quality
Thomas Fitzpatrick, J.D.
Senior Vice President, Legal
Richard Bourgon, Ph.D.
Senior Vice President, Computational Science
Clinton Wu
Vice President, Finance
Board of Directors
Moritz Hartmann
President, Global Head, Roche Information Solutions
Peter Kolchinsky, Ph.D.
Managing Partner, RA Capital Management LP
Vijay Pande, Ph.D.
Founder and Managing Partner, a16z BioHealth
Former Chairman and Chief Executive Officer, NeoGenomics Inc.
Ellen Hukkelhoven, Ph.D.
Head of Biotechnology Investments, Perceptive Advisors
Josh Lauer
Head of Roche Molecular Labs, Roche Diagnostics
Deepa Pakianathan, Ph.D.
Chief Executive Officer, a stealth Biotech Company
Randy Scott, Ph.D.
Chief Executive Officer, Thinking Bench Capital, LLC
Moritz Hartmann
President, Global Head, Roche Information Solutions
Ellen Hukkelhoven, Ph.D.
Head of Biotechnology Investments, Perceptive Advisors
Peter Kolchinsky, Ph.D.
Managing Partner, RA Capital Management LP
Josh Lauer
Head of Roche Molecular Labs, Roche Diagnostics
Deepa Pakianathan, Ph.D.
Chief Executive Officer, a stealth Biotech Company
Vijay Pande, Ph.D.
Founder and Managing Partner, a16z BioHealth
Randy Scott, Ph.D.
Chief Executive Officer, Thinking Bench Capital, LLC
Former Chairman and Chief Executive Officer, NeoGenomics Inc.
Investors
* Funds and accounts advised by T. Rowe Price Associates, Inc.